Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
about
Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cellsCB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioidsThe endocannabinoid system, cannabinoids, and painA cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone lossCannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responsesCB2 receptor-mediated migration of immune cells: it can go either wayCB2 receptors in the brain: role in central immune functionTargeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligandsEmerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammationThe CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetEndocannabinoids in the retina: from marijuana to neuroprotectionThe orphan receptor GPR55 is a novel cannabinoid receptorReduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptorActivation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNSHigh Times for Painful Blues: The Endocannabinoid System in Pain-Depression ComorbidityParsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNSBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemEndogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulationsThe role of endocannabinoids system in fatty liver disease and therapeutic potentialsModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionSex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?Immune mechanisms in cerebral ischemic toleranceExpression Analysis of CB2-GFP BAC Transgenic MiceCrystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolutionWhat we know and do not know about the cannabinoid receptor 2 (CB2)Interaction between Cannabinoid System and Toll-Like Receptors Controls InflammationThe CB2 receptor and its role as a regulator of inflammationThe Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisImpact of Cannabis, Cannabinoids, and Endocannabinoids in the LungsThe human eye expresses high levels of CB1 cannabinoid receptor mRNA and proteinHypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphomaAbsence of a conserved proline and presence of a conserved tyrosine in the CB2 cannabinoid receptor are crucial for its functionThe endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cellsCannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the HippocampusNeuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brainMedical consequences of marijuana use: a review of current literatureAlkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsRole of cannabinoids in multiple sclerosis
P2860
Q21135310-B3714D64-76A6-4ADD-9D94-66A049EE464CQ24528166-FF9BF1FC-E331-4698-B568-D50DF87A1E3CQ24556619-CFDF554F-126F-4009-9124-FFA4B202578DQ24601890-D33BC854-F8B8-48F3-A1E9-92C08974ACCAQ24615787-F2D95B4C-A7FA-4C8D-B6DB-163CA91B73C3Q24633610-2F37D941-887A-40BE-B1AD-A075ED8F3254Q24643591-51EF7FC7-9FA2-468D-8E85-5223C5B7F9DAQ24643895-C3D5E37F-2554-458F-84BE-BAA098975A42Q24643941-9483EB21-17F3-4058-A2FE-777A3757AFA3Q24647850-42153150-5E46-43B1-9882-EC7C4E668778Q24650098-77A16D1D-F544-47B2-B3B4-AA3C8538EB3BQ24656049-D3340566-5432-4E02-8813-2E254DFBB090Q24670137-C7CFA71E-4380-45C1-AD34-407BF4AFA5CDQ24672600-44027A04-0954-432F-9C39-C11C07B15A56Q24683100-E1D26A2B-D33F-46BB-A406-60F6C5A8A638Q26784030-8369F3E4-06C3-49AB-9844-782C01EE5634Q26853436-36078E40-89CE-4C8B-9BC3-A888428D4E68Q26865295-400267A0-77D4-4E7F-89B2-B3217A293AA7Q27009220-9AC0531D-868D-4688-97C0-6D34D2C58B9FQ27009466-01475377-BD30-4C58-BD5F-3EA9A1A1A682Q27014154-4E447393-4731-4895-94D2-E774E255FA3DQ27015088-DD61A1B8-1722-4EF2-8112-EDF94DDDA0DEQ27022067-3A5DB3B8-4A77-435C-8703-38F7BDD45B5FQ27316448-FD4341D0-0D48-49EE-B8F0-EF83F8A178E3Q27666922-120EE3E6-85CF-492E-918B-9528BD64502AQ27686851-1B2DC38C-090D-4A73-8E4C-2AC33A358D3DQ28066215-860AF554-966A-4A8B-A848-3F910A9B9263Q28066700-095D95AB-CD10-4373-90BB-56CFCAABA991Q28068881-06A8EA73-D989-4A6D-8325-485866B545E0Q28077958-8B2C3F30-EC42-4642-B728-8296748A0227Q28141647-EF05D9A3-1B8A-495A-8565-423EAF5F772EQ28190374-7D9C9C3E-4558-4A95-8AF1-65CB657005E5Q28206624-C69164E6-B28B-4D89-8C3D-E6EB922EAE52Q28213500-89D515E4-35C4-4DC6-8656-DAA208FB1551Q28236199-5D30FF11-C5BA-424D-BA61-11443033BD5AQ28275230-F976B0D7-C362-4109-BC27-05C3F1ED5976Q28292744-CAA703A3-0FFC-4A15-AB1E-E65636210B6EQ28301998-D95D55A9-31F4-4409-AC38-38257014973DQ28302804-AD7AD265-FA86-422E-8CC2-2483E96B8590Q28305413-D66518AC-2BA6-4C84-BDE9-13E2E202F5DF
P2860
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Expression of central and peri ...... s and leukocyte subpopulations
@ast
Expression of central and peri ...... s and leukocyte subpopulations
@en
Expression of central and peri ...... s and leukocyte subpopulations
@en-gb
Expression of central and peri ...... s and leukocyte subpopulations
@nl
type
label
Expression of central and peri ...... s and leukocyte subpopulations
@ast
Expression of central and peri ...... s and leukocyte subpopulations
@en
Expression of central and peri ...... s and leukocyte subpopulations
@en-gb
Expression of central and peri ...... s and leukocyte subpopulations
@nl
prefLabel
Expression of central and peri ...... s and leukocyte subpopulations
@ast
Expression of central and peri ...... s and leukocyte subpopulations
@en
Expression of central and peri ...... s and leukocyte subpopulations
@en-gb
Expression of central and peri ...... s and leukocyte subpopulations
@nl
P2093
P2860
P921
P3181
P1433
P1476
Expression of central and peri ...... s and leukocyte subpopulations
@en
P2093
D Carrière
D Dussossoy
J Marchand
M Bouaboula
P Casellas
S Galiègue
P2860
P3181
P356
10.1111/J.1432-1033.1995.TB20780.X
P407
P577
1995-08-15T00:00:00Z